US5449670A
(en)
*
|
1983-05-20 |
1995-09-12 |
Skinner; Wilfred A. |
Composition and method for the transdermal delivery of bioactive peptides
|
US4557934A
(en)
*
|
1983-06-21 |
1985-12-10 |
The Procter & Gamble Company |
Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
|
US4931283A
(en)
*
|
1983-12-22 |
1990-06-05 |
American Home Products Corp. (Del) |
Menthol enhancement of transdermal drug delivery
|
US4933184A
(en)
*
|
1983-12-22 |
1990-06-12 |
American Home Products Corp. (Del) |
Menthol enhancement of transdermal drug delivery
|
JPH0627074B2
(ja)
*
|
1984-07-25 |
1994-04-13 |
日東電工株式会社 |
医薬組成物
|
US4626539A
(en)
*
|
1984-08-10 |
1986-12-02 |
E. I. Dupont De Nemours And Company |
Trandermal delivery of opioids
|
US4927687A
(en)
*
|
1984-10-01 |
1990-05-22 |
Biotek, Inc. |
Sustained release transdermal drug delivery composition
|
US4568343A
(en)
*
|
1984-10-09 |
1986-02-04 |
Alza Corporation |
Skin permeation enhancer compositions
|
DE3570598D1
(en)
*
|
1984-11-15 |
1989-07-06 |
Nitto Denko Corp |
Composition for percutaneous administration
|
JPS61130207A
(ja)
*
|
1984-11-30 |
1986-06-18 |
Sunstar Inc |
養毛剤
|
US4706676A
(en)
*
|
1985-02-11 |
1987-11-17 |
The United States Of America As Represented By The Secretary Of The Army |
Dermal substance collection device
|
CA1288698C
(en)
*
|
1985-08-30 |
1991-09-10 |
Yie W. Chien |
Transdermal anti-anginal pharmaceutical dosage
|
DE3531545A1
(de)
*
|
1985-09-04 |
1987-03-05 |
Goedecke Ag |
Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
|
US4837026A
(en)
*
|
1985-10-03 |
1989-06-06 |
Rajakhyaksha Vithal J |
Transdermal and systemic preparation and method
|
US5023252A
(en)
*
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
JPS63502282A
(ja)
*
|
1986-01-31 |
1988-09-01 |
ホイットビ−・リサ−チ・インコ−ポレ−テッド |
1−置換アザシクロアルカン類より成る組成物とその用法
|
US5204339A
(en)
*
|
1986-01-31 |
1993-04-20 |
Whitby Research, Inc. |
Penetration enhancers for transdermal delivery of systemic agents
|
US5256647A
(en)
*
|
1986-01-31 |
1993-10-26 |
Whitby Research, Inc. |
Compositions comprising 1-substituted azacycloalkanes
|
US4992422A
(en)
*
|
1986-01-31 |
1991-02-12 |
Whitby Research, Inc. |
Compositions comprising 1-substituted azacycloalkanes
|
AU599964B2
(en)
*
|
1986-01-31 |
1990-08-02 |
Nelson Research & Development Company |
Topical pharmaceuticals dye compositions, and plant nutrient compositions comprising 1-substituted azacycloalkanes as penetration enhancers
|
US4755535A
(en)
*
|
1986-04-23 |
1988-07-05 |
Nelson Research & Development Co. |
Compositions comprising 1-substituted azacycloalkenes
|
US4801586A
(en)
*
|
1986-04-23 |
1989-01-31 |
Nelson Research & Development Co. |
Penetration enhancers for transdermal delivery of systemic agents
|
US5142044A
(en)
*
|
1986-04-23 |
1992-08-25 |
Whitby Research, Inc. |
Penetration enhancers for transdermal delivery of systemic agents
|
CH666621A5
(de)
*
|
1986-06-27 |
1988-08-15 |
Ciba Geigy Ag |
Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
|
CA1319613C
(en)
*
|
1986-10-07 |
1993-06-29 |
Gevork Minaskanian |
Penetration enhancers for transdermal delivery of systemic agents
|
US5196410A
(en)
*
|
1986-10-31 |
1993-03-23 |
Pfizer Inc. |
Transdermal flux enhancing compositions
|
US4959365A
(en)
*
|
1986-10-31 |
1990-09-25 |
Pfizer Inc. |
Topical compositions of lipophilic pharmaceuticals agents
|
MY102980A
(en)
*
|
1986-10-31 |
1993-03-31 |
Pfizer |
Transdermal flux enhancing compositions
|
US4873266A
(en)
*
|
1987-01-16 |
1989-10-10 |
American Home Products Corp. |
Menthone enhancement of transdermal drug delivery
|
US4888362A
(en)
*
|
1987-01-16 |
1989-12-19 |
American Home Products Corp. |
Eugenol enhancement of transdermal drug delivery
|
US4888360A
(en)
*
|
1987-01-16 |
1989-12-19 |
American Home Products Corporation |
Carvone enhancement of transdermal drug delivery
|
US4746515A
(en)
*
|
1987-02-26 |
1988-05-24 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monolaurate
|
US4940586A
(en)
*
|
1987-02-26 |
1990-07-10 |
Alza Corporation |
Skin permeation enhancer compositions using sucrose esters
|
US4865848A
(en)
*
|
1987-02-26 |
1989-09-12 |
Alza Corporation |
Skin permeation enhancer compositions using sucrose esters
|
US5051260A
(en)
*
|
1987-07-16 |
1991-09-24 |
The Regents Of The University Of California |
Method and composition for enhancing the cutaneous penetration of pharmacologically active agents
|
US5045317A
(en)
*
|
1987-07-16 |
1991-09-03 |
The Regents Of The University Of California |
Enhancing the cutaneous penetration of pharmacologically active agents
|
US4971800A
(en)
*
|
1988-07-08 |
1990-11-20 |
The Regents Of The University Of California |
Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents
|
US4764379A
(en)
*
|
1987-08-24 |
1988-08-16 |
Alza Corporation |
Transdermal drug delivery device with dual permeation enhancers
|
US4820720A
(en)
*
|
1987-08-24 |
1989-04-11 |
Alza Corporation |
Transdermal drug composition with dual permeation enhancers
|
DE3871464D1
(de)
*
|
1987-08-28 |
1992-07-02 |
Lilly Co Eli |
Die permeation verbessernde zusammensetzung.
|
US5196416A
(en)
*
|
1987-08-28 |
1993-03-23 |
Eli Lilly And Company |
Transdermal flux-enhancing pharmaceutical compositions comprising azone, ethanol and water
|
US4879275A
(en)
*
|
1987-09-30 |
1989-11-07 |
Nelson Research & Development Co. |
Penetration enhancers for transdermal delivery of systemic agent
|
US4920101A
(en)
*
|
1987-09-30 |
1990-04-24 |
Nelson Research & Development Co. |
Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
|
US4863738A
(en)
*
|
1987-11-23 |
1989-09-05 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monooleate
|
US4906475A
(en)
*
|
1988-02-16 |
1990-03-06 |
Paco Pharmaceutical Services |
Estradiol transdermal delivery system
|
US5641504A
(en)
*
|
1988-06-09 |
1997-06-24 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monolinoleate
|
US5378730A
(en)
*
|
1988-06-09 |
1995-01-03 |
Alza Corporation |
Permeation enhancer comprising ethanol and monoglycerides
|
US4960771A
(en)
*
|
1988-07-12 |
1990-10-02 |
Rajadhyaksha Vithal J |
Oxazolidinone penetration enhancing compounds
|
US4975271A
(en)
*
|
1988-12-19 |
1990-12-04 |
Vipont Pharmaceutical, Inc. |
Muscosal delivery systems for treatment of periodontal disease
|
DE3843557A1
(de)
*
|
1988-12-23 |
1990-06-28 |
Beiersdorf Ag |
Transdermales therapeutisches system zur verabreichung von clenbuterol
|
DE3905050A1
(de)
|
1989-02-18 |
1990-08-30 |
Lohmann Therapie Syst Lts |
Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (ii)
|
US5059426A
(en)
*
|
1989-03-22 |
1991-10-22 |
Cygnus Therapeutic Systems |
Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
|
US4973468A
(en)
*
|
1989-03-22 |
1990-11-27 |
Cygnus Research Corporation |
Skin permeation enhancer compositions
|
US5053227A
(en)
*
|
1989-03-22 |
1991-10-01 |
Cygnus Therapeutic Systems |
Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
|
US4958032A
(en)
*
|
1989-04-05 |
1990-09-18 |
Lenick Jr Anthony J O |
N-alkoxylated ether 2-pyrrolidones
|
US6028105A
(en)
*
|
1989-04-06 |
2000-02-22 |
Nigra; Thomas P. |
Topical drug delivery composition and method
|
JP2831030B2
(ja)
*
|
1989-05-12 |
1998-12-02 |
学校法人城西大学 |
3’‐アジド‐3’デオキシチミジンを有効成分とする経皮投与製剤用組成物
|
US5023085A
(en)
*
|
1989-11-29 |
1991-06-11 |
Pfizer Inc. |
Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
|
US5221254A
(en)
*
|
1991-04-02 |
1993-06-22 |
Alza Corporation |
Method for reducing sensation in iontophoretic drug delivery
|
DE4115849A1
(de)
*
|
1991-05-15 |
1992-11-19 |
Lohmann Therapie Syst Lts |
Penetrationsfoerdernde substanz
|
US5229130A
(en)
*
|
1991-12-20 |
1993-07-20 |
Cygnus Therapeutics Systems |
Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
|
AU666735B2
(en)
*
|
1992-05-13 |
1996-02-22 |
Alza Corporation |
Transdermal administration of oxybutynin
|
US5900250A
(en)
*
|
1992-05-13 |
1999-05-04 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for oxybutnin
|
DE69407061T2
(de)
*
|
1992-06-02 |
1998-06-04 |
Alza Corp |
Abgabevorrichtung zur elektrischen übertragung von arzneimitteln
|
GB2273044B
(en)
*
|
1992-12-02 |
1997-04-09 |
Pacific Chem Co Ltd |
Medicinal patches for percutaneous administration
|
US5776923A
(en)
*
|
1993-01-19 |
1998-07-07 |
Endorecherche, Inc. |
Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
|
WO1994016709A2
(en)
*
|
1993-01-19 |
1994-08-04 |
Endorecherche Inc. |
Therapeutic uses and delivery systems of dehydroepiandrosterone
|
US5451407A
(en)
*
|
1993-06-21 |
1995-09-19 |
Alza Corporation |
Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
|
EP0705097B2
(de)
*
|
1993-06-25 |
2004-01-14 |
Alza Corporation |
Einarbeitung eines poly-n-vinylamids in ein transdermales system
|
EP0721348B1
(de)
*
|
1993-09-29 |
1999-09-01 |
Alza Corporation |
Hautpermeabilitaetserhöher bestehend aus monoglycerid/laktat estern
|
AU695170B2
(en)
*
|
1994-12-21 |
1998-08-06 |
Theratech, Inc. |
Transdermal delivery system with adhesive overlay and peel seal disc
|
US5837281A
(en)
|
1995-03-17 |
1998-11-17 |
Takeda Chemical Industries, Ltd. |
Stabilized interface for iontophoresis
|
US5785991A
(en)
*
|
1995-06-07 |
1998-07-28 |
Alza Corporation |
Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
|
US5703104A
(en)
*
|
1995-07-07 |
1997-12-30 |
Durham Pharmaceuticals Llc |
Cyclic amides and derivatives thereof
|
US5707612A
(en)
*
|
1996-04-08 |
1998-01-13 |
Alzo, Inc. |
Use urethane polymers of castor oil skin and personal care product compositiions
|
US20030045492A1
(en)
*
|
1997-08-13 |
2003-03-06 |
Tang De-Chu C. |
Vaccination by topical application of recombinant vectors
|
US6706693B1
(en)
|
1997-08-13 |
2004-03-16 |
The Uab Research Foundation |
Vaccination by topical application of genetic vectors
|
US6348450B1
(en)
|
1997-08-13 |
2002-02-19 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom and uses thereof
|
US20030125278A1
(en)
*
|
1997-08-13 |
2003-07-03 |
Tang De-Chu C. |
Immunization of animals by topical applications of a salmonella-based vector
|
US6716823B1
(en)
|
1997-08-13 |
2004-04-06 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom, and uses thereof
|
US6267984B1
(en)
|
1997-12-22 |
2001-07-31 |
Alza Corporation |
Skin permeation enhancer compositions comprising a monoglyceride and ethyl palmitate
|
US6454681B1
(en)
|
1998-01-05 |
2002-09-24 |
Thomas Brassil |
Hand rehabilitation glove
|
US20070087901A1
(en)
*
|
1998-01-05 |
2007-04-19 |
Brassil Thomas W |
Therapy system
|
US20040009936A1
(en)
*
|
1999-05-03 |
2004-01-15 |
Tang De-Chu C. |
Vaccine and drug delivery by topical application of vectors and vector extracts
|
US6544541B1
(en)
|
1999-06-02 |
2003-04-08 |
Cardiovascular Solutions, Inc. |
Devices and compounds for treating arterial restenosis
|
US7029694B2
(en)
|
2000-04-26 |
2006-04-18 |
Watson Laboratories, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
AU2001282064B2
(en)
*
|
2000-08-03 |
2007-02-01 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
US20020119187A1
(en)
*
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
EP1390084B1
(de)
|
2001-05-01 |
2011-03-23 |
A.V. Topchiev Institute of Petrochemical Synthesis |
Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung
|
US20090162342A1
(en)
*
|
2001-06-07 |
2009-06-25 |
Sanomune Inc. |
Therapeutic uses of glandular kallikrein
|
WO2003000158A1
(en)
*
|
2001-06-22 |
2003-01-03 |
Bentley Pharmaceuticals, Inc. |
Pharmaceutical composition
|
US20040033253A1
(en)
*
|
2002-02-19 |
2004-02-19 |
Ihor Shevchuk |
Acyl opioid antagonists
|
MY139721A
(en)
*
|
2002-04-19 |
2009-10-30 |
Cpex Pharmaceuticals Inc |
Pharmaceutical composition
|
GB0210397D0
(en)
*
|
2002-05-07 |
2002-06-12 |
Ferring Bv |
Pharmaceutical formulations
|
KR101407131B1
(ko)
|
2002-06-10 |
2014-06-19 |
유로-셀티크 소시에떼 아노뉨 |
경피 전달 장치에 포함된 활성 성분의 오용을 방지하는 경피 전달 장치의 처리 시스템
|
ES2294344T3
(es)
*
|
2002-08-02 |
2008-04-01 |
Ab Science |
2-(3-aminoaril)amino-4-aril-tiazoles y su utilizacion como inhibidores de c-kit.
|
US8450302B2
(en)
*
|
2002-08-02 |
2013-05-28 |
Ab Science |
2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
|
US20030049307A1
(en)
*
|
2002-08-15 |
2003-03-13 |
Gyurik Robert J. |
Pharmaceutical composition
|
WO2004017941A2
(en)
*
|
2002-08-20 |
2004-03-04 |
Euro-Celtique, S.A. |
Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist
|
US20080020028A1
(en)
*
|
2003-08-20 |
2008-01-24 |
Euro-Celtique S.A. |
Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
|
PT1670433E
(pt)
|
2003-10-10 |
2012-02-08 |
Ferring Bv |
Fórmula farmacológica transdérmica para a minimização de resíduos na pele
|
CN1950347B
(zh)
*
|
2003-10-23 |
2012-04-04 |
Ab科学公司 |
作为酪氨酸激酶抑制剂的2-氨基芳基噁唑化合物
|
PT1682537E
(pt)
|
2003-11-05 |
2012-06-20 |
Sarcode Bioscience Inc |
Moduladores de adesão celular
|
US7105263B2
(en)
*
|
2003-12-30 |
2006-09-12 |
Samsung Electronics Company |
Dry toner comprising encapsulated pigment, methods and uses
|
US8658201B2
(en)
|
2004-01-30 |
2014-02-25 |
Corium International, Inc. |
Rapidly dissolving film for delivery of an active agent
|
WO2005097083A2
(en)
*
|
2004-03-30 |
2005-10-20 |
Dermatrends,Inc. |
Transdermal administration of proton pump inhibitors
|
WO2005110418A2
(en)
|
2004-05-07 |
2005-11-24 |
Phytotox Limited |
Transdermal administration of phycotoxins
|
US20060008432A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Sebastiano Scarampi |
Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
|
JP2008531581A
(ja)
*
|
2005-02-23 |
2008-08-14 |
ユーエービー リサーチ ファウンデーション |
アルキル−グリコシドで増強されたワクチン接種
|
US20080242704A1
(en)
|
2005-04-04 |
2008-10-02 |
Ab Science |
Substituted Oxazole Derivatives and their Use as Tyrosine Kinase Inhibitors
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
TWI366460B
(en)
|
2005-06-16 |
2012-06-21 |
Euro Celtique Sa |
Cannabinoid active pharmaceutical ingredient for improved dosage forms
|
US8153162B2
(en)
|
2005-09-27 |
2012-04-10 |
Tissuetech, Inc. |
Purified amniotic membrane compositions and methods of use
|
US8187639B2
(en)
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
CA2646667C
(en)
|
2006-04-21 |
2014-03-11 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
US7879344B2
(en)
*
|
2006-06-29 |
2011-02-01 |
Kimberly-Clark Worldwide, Inc. |
Transdermal delivery of oleocanthal for relief of inflammation
|
WO2008067991A2
(en)
*
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
WO2008141176A1
(en)
*
|
2007-05-11 |
2008-11-20 |
The Trustees Of The University Of Pennsylvania |
Methods of treatment of skin ulcers
|
US9511016B2
(en)
*
|
2007-06-12 |
2016-12-06 |
Epicentrx, Inc. |
Topical composition for treating pain
|
US20080311058A1
(en)
*
|
2007-06-18 |
2008-12-18 |
Connopco, Inc., D/B/A Unilever |
Stable high internal phase emulsions and compositions comprising the same
|
RU2472539C2
(ru)
|
2007-08-06 |
2013-01-20 |
Аллерган, Инк. |
Способы и устройства для доставки препарата десмопрессина
|
CA2866527C
(en)
|
2007-10-10 |
2018-07-03 |
Bryan B. Fuller |
Use of isoeugenol esters in treating hyperpigmentation
|
ES2830024T3
(es)
|
2007-10-19 |
2021-06-02 |
Novartis Ag |
Composiciones y métodos para el tratamiento del edema macular
|
US20090123504A1
(en)
*
|
2007-11-12 |
2009-05-14 |
Kimberly-Clark Worldwide, Inc. |
Olive oil formulation for pain relief
|
US8425882B2
(en)
*
|
2008-04-01 |
2013-04-23 |
Conopco, Inc. |
In-shower and bath compositions
|
ES2763703T3
(es)
*
|
2008-04-15 |
2020-05-29 |
Sarcode Bioscience Inc |
Antagonistas de LFA-1 tópicos utilizados en el tratamiento localizado de trastornos inmunes
|
US11963995B2
(en)
|
2008-05-21 |
2024-04-23 |
Ferring B.V. |
Methods comprising desmopressin
|
US20100286045A1
(en)
|
2008-05-21 |
2010-11-11 |
Bjarke Mirner Klein |
Methods comprising desmopressin
|
PT3085381T
(pt)
|
2008-05-21 |
2018-05-18 |
Ferring Bv |
Desmopressina orodispersível para aumentar o período inicial de sono não perturbado pela noctúria
|
US20090304776A1
(en)
*
|
2008-06-06 |
2009-12-10 |
Totada Shantha |
Transmucosal delivery of therapeutic agents and methods of use thereof
|
US7883487B2
(en)
*
|
2008-06-16 |
2011-02-08 |
Shantha Totada R |
Transdermal local anesthetic patch with injection port
|
GB0819594D0
(en)
|
2008-10-24 |
2008-12-03 |
Univ Coimbrra |
Process
|
US8299127B2
(en)
*
|
2009-03-11 |
2012-10-30 |
Conopco, Inc. |
Method and composition for evenly applying water soluble actives
|
US8241614B2
(en)
*
|
2009-11-30 |
2012-08-14 |
Conopco, Inc |
Compositions and methods for imparting a sunless tan
|
AR079993A1
(es)
|
2010-01-12 |
2012-03-07 |
Ab Science |
Derivados de azol, composiciones farmaceuticas y sus usos para tratar trastornos mediados por una sobreactividad de quinasas
|
US20120302577A1
(en)
|
2010-01-28 |
2012-11-29 |
Ab Science |
Treatment of gist with masitinib
|
CA2797033C
(en)
|
2010-04-22 |
2021-10-19 |
Longevity Biotech, Inc. |
Highly active polypeptides and methods of making and using the same
|
US8821839B2
(en)
|
2010-10-22 |
2014-09-02 |
Conopco, Inc. |
Compositions and methods for imparting a sunless tan with a vicinal diamine
|
US8398959B2
(en)
|
2010-12-06 |
2013-03-19 |
Conopco, Inc. |
Compositions and methods for imparting a sunless tan with functionalized adjuvants
|
WO2012116452A1
(en)
|
2011-03-03 |
2012-09-07 |
Denovamed Inc. |
Antimicrobial/adjuvant compounds and methods
|
ES2822301T3
(es)
|
2011-06-10 |
2021-04-30 |
Tissuetech Inc |
Métodos de procesamiento de tejidos de soporte fetal
|
CN103764150A
(zh)
|
2011-06-29 |
2014-04-30 |
阿勒根公司 |
阿卡他定在治疗荨麻疹中的用途
|
MX2014001079A
(es)
|
2011-07-27 |
2014-09-12 |
Ab Science |
Derivados de oxazoly tiazol como inhibidores de la proteina quinasa selectiva (c-kit).
|
WO2013032938A1
(en)
|
2011-08-26 |
2013-03-07 |
Tissuetech, Inc. |
Methods of sterilizing fetal support tissues
|
US8961942B2
(en)
|
2011-12-13 |
2015-02-24 |
Conopco, Inc. |
Sunless tanning compositions with adjuvants comprising sulfur comprising moieties
|
US20130315891A1
(en)
|
2012-05-25 |
2013-11-28 |
Matthew Charles |
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
|
CA2880085C
(en)
|
2012-06-04 |
2021-09-07 |
Diamedica Inc. |
Human tissue kallikrein 1 glycosylation isoforms
|
EP2968469A4
(de)
|
2013-03-15 |
2016-08-31 |
Longevity Biotech Inc |
Peptide mit nichtnatürlichen aminosäuren und verfahren zur herstellung und verwendung davon
|
DK3024474T3
(da)
|
2013-07-23 |
2022-03-28 |
Serenity Pharmaceuticals Llc |
Sammensætninger omfattende desmopressin i kombination med en beta-3-adrenoreceptor-agonist
|
CN106414433A
(zh)
|
2014-03-24 |
2017-02-15 |
Ab科学有限公司 |
作为脾酪氨酸激酶抑制剂的二氮杂螺烷酮取代的噁唑衍生物
|
KR20170070008A
(ko)
|
2014-08-15 |
2017-06-21 |
더 존스 홉킨스 유니버시티 |
조직 복원용 복합 재료
|
WO2016081599A1
(en)
|
2014-11-18 |
2016-05-26 |
Rutgers, The State University Of New Jersey |
Novel mitochondrial uncouplers for treatment of metabolic diseases and cancer
|
KR20170097045A
(ko)
|
2014-11-20 |
2017-08-25 |
알레간 인코포레이티드 |
알파-아드레날린성 수용체 길항제와 조합된 데스모프레신을 포함하는 방법 및 조성물
|
EP3053920B1
(de)
|
2015-02-05 |
2020-04-08 |
AB Science |
Verbindungen mit antitumoraktivität
|
ES2919964T3
(es)
|
2015-08-17 |
2022-07-29 |
Univ Johns Hopkins |
Material compuesto que se forma in situ para la restauración de tejido
|
EP3144307A1
(de)
|
2015-09-18 |
2017-03-22 |
AB Science |
Neue oxazol derivaten als syk kinasehemmer
|
TW201733600A
(zh)
|
2016-01-29 |
2017-10-01 |
帝聖工業公司 |
胎兒扶持組織物及使用方法
|
CA3024610A1
(en)
|
2016-05-18 |
2017-11-23 |
David J. Augeri |
Novel mitochondrial uncouplers for treatment of metabolic diseases and cancer
|
EP3592377A4
(de)
|
2017-03-09 |
2021-02-17 |
Diamedica Inc. |
Darreichungsformen von gewebekallikrein 1
|
ES2942848T3
(es)
|
2018-03-05 |
2023-06-07 |
Denovamed Inc |
Derivados de tiofeno-2-amida sustituidos con difenilo y composiciones farmacéuticas de los mismos útiles como antimicrobiano
|
AU2019265839A1
(en)
|
2018-05-09 |
2020-12-03 |
The Johns Hopkins University |
Nanofiber-hydrogel composites for enhanced soft tissue replacement and regeneration
|
CN112384258A
(zh)
|
2018-05-09 |
2021-02-19 |
约翰·霍普金斯大学 |
用于细胞和组织递送的纳米纤维-水凝胶复合物
|